Form 8-K - Current report:
SEC Accession No. 0001140361-25-003645
Filing Date
2025-02-10
Accepted
2025-02-10 08:11:31
Documents
57
Period of Report
2025-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20043150_8k.htm   iXBRL 8-K 47982
2 EXHIBIT 4.1 ef20043150_ex4-1.htm EX-4.1 91568
3 EXHIBIT 4.2 ef20043150_ex4-2.htm EX-4.2 110618
4 EXHIBIT 10.1 ef20043150_ex10-1.htm EX-10.1 215932
5 EXHIBIT 10.2 ef20043150_ex10-2.htm EX-10.2 205212
6 EXHIBIT 10.3 ef20043150_ex10-3.htm EX-10.3 140340
7 EXHIBIT 99.1 ef20043150_ex99-1.htm EX-99.1 24207
8 EXHIBIT 99.2 ef20043150_ex99-2.htm EX-99.2 67973
9 EXHIBIT 99.3 ef20043150_ex99-3.htm EX-99.3 21156
13 ef20043150_ex99-2slide1.jpg GRAPHIC 78464
14 ef20043150_ex99-2slide2.jpg GRAPHIC 398665
15 ef20043150_ex99-2slide3.jpg GRAPHIC 187755
16 ef20043150_ex99-2slide4.jpg GRAPHIC 172850
17 ef20043150_ex99-2slide5.jpg GRAPHIC 150927
18 ef20043150_ex99-2slide6.jpg GRAPHIC 176214
19 ef20043150_ex99-2slide7.jpg GRAPHIC 140973
20 ef20043150_ex99-2slide8.jpg GRAPHIC 176377
21 ef20043150_ex99-2slide9.jpg GRAPHIC 139210
22 ef20043150_ex99-2slide10.jpg GRAPHIC 153027
23 ef20043150_ex99-2slide11.jpg GRAPHIC 153804
24 ef20043150_ex99-2slide12.jpg GRAPHIC 89318
25 ef20043150_ex99-2slide13.jpg GRAPHIC 74388
26 ef20043150_ex99-2slide14.jpg GRAPHIC 144470
27 ef20043150_ex99-2slide15.jpg GRAPHIC 116437
28 ef20043150_ex99-2slide16.jpg GRAPHIC 90652
29 ef20043150_ex99-2slide17.jpg GRAPHIC 80799
30 ef20043150_ex99-2slide18.jpg GRAPHIC 103232
31 ef20043150_ex99-2slide19.jpg GRAPHIC 147856
32 ef20043150_ex99-2slide20.jpg GRAPHIC 156905
33 ef20043150_ex99-2slide21.jpg GRAPHIC 142734
34 ef20043150_ex99-2slide22.jpg GRAPHIC 98011
35 ef20043150_ex99-2slide23.jpg GRAPHIC 74378
36 ef20043150_ex99-2slide24.jpg GRAPHIC 184628
37 ef20043150_ex99-2slide25.jpg GRAPHIC 154834
38 ef20043150_ex99-2slide26.jpg GRAPHIC 151694
39 ef20043150_ex99-2slide27.jpg GRAPHIC 132152
40 ef20043150_ex99-2slide28.jpg GRAPHIC 72298
41 ef20043150_ex99-2slide29.jpg GRAPHIC 136728
42 ef20043150_ex99-2slide30.jpg GRAPHIC 192979
43 ef20043150_ex99-2slide31.jpg GRAPHIC 69513
44 ef20043150_ex99-2slide32.jpg GRAPHIC 174113
45 ef20043150_ex99-2slide33.jpg GRAPHIC 118032
46 ef20043150_ex99-2slide34.jpg GRAPHIC 99398
47 ef20043150_ex99-2slide35.jpg GRAPHIC 83411
48 image00001.jpg GRAPHIC 3564
  Complete submission text file 0001140361-25-003645.txt   7940569

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA grce-20250210.xsd EX-101.SCH 3976
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE grce-20250210_lab.xml EX-101.LAB 21966
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grce-20250210_pre.xml EX-101.PRE 16040
59 EXTRACTED XBRL INSTANCE DOCUMENT ef20043150_8k_htm.xml XML 4232
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 25603721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)